Related Experiment Video
Updated: Apr 15, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis
1Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, No 188 ShiziStreet, 215006, Suzhou, China.
Objective:
To determine the correlation between rheumatoid arthritis (RA) and polymorphisms of the matrix metalloproteinase (MMP) genes MMP-1 and MMP-3.
Background:
The 1607 1G/2G and 1171 5A/6A polymorphisms of MMP genes MMP-1 and MMP-3 have been discovered to be functional, and may be conducive to RA. In order to determine whether MMP-1 and MMP-3 gene polymorphisms correlate with RA development, we performed a meta-analysis to further validate the function of these polymorphisms in RA.
Methods:
We searched PubMed, ISI Web of Knowledge, MEDLINE, Embase, Google Scholar Chinese Biomedical Literature Database, and Wanfang Data to identify all published case-control studies on the MMP-1-1607 1G/2G and MMP-3-1171 5A/6A polymorphisms and RA risk. Odds ratios (OR) and 95 % confidence intervals (CI) were used to estimate the association between these polymorphisms and RA risk.
Results:
After being assessed, five articles fulfilled the inclusion criteria. To assess associations, the pooled OR with 95 % CIs was calculated. Neither the MMP-1-1607 1G/2G nor the MMP-3-1171 5A/6A polymorphism was statistically associated with RA in any of the five models, nor in the subgroup analysis models of MMP-3-1171 5A/6A in Caucasian and Asian patients.
Conclusion:
Our study suggests that MMP-1 and MMP-3 polymorphisms have no significant association with the risk of RA.
Insights
This meta-analysis found no significant link between rheumatoid arthritis (RA) and specific matrix metalloproteinase (MMP) gene polymorphisms (MMP-1 and MMP-3). Further research is needed to understand the role of these MMP gene variations in RA development.
Area of Science:
- Genetics and Rheumatology
- Molecular Biology
- Disease Association Studies
Background:
- Matrix metalloproteinase (MMP) genes, specifically MMP-1 and MMP-3, possess functional polymorphisms (1607 1G/2G and 1171 5A/6A) that have been hypothesized to contribute to rheumatoid arthritis (RA) development.
- Previous research suggests a potential role for these MMP gene polymorphisms in the pathogenesis of RA, necessitating further investigation.
Purpose of the Study:
- To conduct a comprehensive meta-analysis to determine the correlation between rheumatoid arthritis (RA) and the MMP-1 (1607 1G/2G) and MMP-3 (1171 5A/6A) gene polymorphisms.
- To validate the functional significance of these specific MMP gene polymorphisms in the context of RA risk.
Main Methods:
- A systematic literature search was performed across multiple databases (PubMed, ISI Web of Knowledge, MEDLINE, Embase, Google Scholar, Chinese Biomedical Literature Database, Wanfang Data) to identify relevant case-control studies.
- Studies investigating the association between MMP-1-1607 1G/2G and MMP-3-1171 5A/6A polymorphisms and RA risk were included.
- Statistical analysis involved calculating pooled odds ratios (OR) with 95% confidence intervals (CI) to assess the strength of association.
Main Results:
- Five articles met the inclusion criteria for the meta-analysis.
- Neither the MMP-1-1607 1G/2G nor the MMP-3-1171 5A/6A polymorphism showed a statistically significant association with RA risk across all five genetic models.
- Subgroup analysis for the MMP-3-1171 5A/6A polymorphism in Caucasian and Asian populations also revealed no significant association with RA.
Conclusions:
- The findings suggest that the investigated MMP-1 and MMP-3 gene polymorphisms (1607 1G/2G and 1171 5A/6A) are not significantly associated with the risk of developing rheumatoid arthritis.
- These specific MMP gene variations do not appear to be major genetic risk factors for RA based on current evidence.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Role of Matrix Metalloproteases in Degradation of ECM
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

